Approval · Notice of Compliance 19869 · 2017
CETROTIDE: Notice of Compliance 19869
Issued September 27, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19869
- Date
- September 27, 2017
- Company
- Emd Serono A Division Of Emd Inc CanadaMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update the product monograph and package insert to remove references to the discontinued 3 mg strength formulation
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CETROTIDE | Not yet assigned | — |
Medicinal ingredients
- CETRORELIX ACETATE 0.25 MG per VIAL